Designation of the Company's Shares as Securities Under Supervision (Examination Pending)
Medical Net,Inc. (filing company)
The Company's shares (Tokyo Stock Exchange Growth Market)
The Company continued to fail to meet the market capitalization criterion among the Growth Market's listing maintenance criteria, and compliance could not be confirmed at the end of the improvement period. In addition, the Company has applied to transfer its market segment to the Standard Market.
Related procedures
Designation as Securities Under Supervision (Examination Pending)
Tokyo Stock Exchange, Inc.
The Company will continue the market segment transfer application process so that the designation as Securities Under Supervision (Examination Pending) can be lifted. If the market segment transfer review is approved, the designation as Securities Under Supervision (Examination Pending) will be lifted. Trading in the Company's shares on the Tokyo Stock Exchange Growth Market will remain available as usual after 1 June 2026.
| Item | Details |
|---|---|
| Event name | Designation of the Company's Shares as Securities Under Supervision (Examination Pending) |
| Date of occurrence | 1 June 2026 (date of designation as Securities Under Supervision (Examination Pending)) |
| Subject Entity | Medical Net,Inc. (filing company) |
| Target Locations / Products | The Company's shares (Tokyo Stock Exchange Growth Market) |
| Cause | The Company continued to fail to meet the market capitalization criterion among the Growth Market's listing maintenance criteria, and compliance could not be confirmed at the end of the improvement period. In addition, the Company has applied to transfer its market segment to the Standard Market. |
| Type of litigation or proceeding | Designation as Securities Under Supervision (Examination Pending) |
| Court or authority | Tokyo Stock Exchange, Inc. |
| Date of filing / date of action | 1 June 2026 (date of designation as Securities Under Supervision (Examination Pending)) |
| Outlook | The Company will continue the market segment transfer application process so that the designation as Securities Under Supervision (Examination Pending) can be lifted. If the market segment transfer review is approved, the designation as Securities Under Supervision (Examination Pending) will be lifted. Trading in the Company's shares on the Tokyo Stock Exchange Growth Market will remain available as usual after 1 June 2026. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company has continued to fail to meet the market capitalization criterion among the Growth Market's listing maintenance criteria, and compliance could not be confirmed as of 31 May 2026, when the improvement period ended. In addition, the Company has applied to transfer its market segment to the Standard Market.